4//SEC Filing
Guyer Charles Greg 4
Accession 0001048477-24-000154
CIK 0001048477other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 2:44 PM ET
Size
6.6 KB
Accession
0001048477-24-000154
Insider Transaction Report
Form 4
Guyer Charles Greg
EVP, Chief Technical Officer
Transactions
- Award
Common Stock
2024-10-31$56.01/sh+55$3,080→ 74,187 total - Sale
Common Stock
2024-11-12$66.37/sh−5,278$350,324→ 68,909 total
Footnotes (2)
- [F1]Represents the shares acquired by the reporting person on October 31, 2024, pursuant to the issuer's Employee Stock Purchase Plan.
- [F2]The price in column 4 is the weighted average price. The purchase price actually received ranged from $66.37 to $66.395. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeother
Related Parties
1- filerCIK 0001811096
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 2:44 PM ET
- Size
- 6.6 KB